Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Progenika Biopharma S.A.
DescriptionDNA microarray that detects 189 genetic mutations to screen patients for familial hypercholesterolemia
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationMetabolic, Diagnostic
Indication DetailsDiagnose familial hypercholesterolemia (FH)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today